Navigation Links
Vermillion Reports First Quarter 2013 Results

sands, Except Share and Per Share Amounts)(Unaudited)Three Months Ended March 31, 20132012Revenue:Product


114114Total revenue

328312Cost of revenue:Product

3738Total cost of revenue

3738Gross profit

291274Operating expenses:Research and development(1)

484452Sales and marketing(2)

1,0721,518General and administrative(3)

1,337468Total operating expenses

2,8932,438Loss from operations

(2,602)(2,164)Interest income

28Interest expense

-(65)Gain on litigation settlement, net

-379Reorganization items

-88Other income (expense), net

29(22)Loss before income taxes

(2,571)(1,776)Income tax benefit (expense)

--Net loss

(1,776)Net loss per share - basic and diluted

(0.12)Weighted average common shares used to compute basic and diluted net loss per common share

15,201,61614,903,455Net loss

(2,571)(1,776)Foreign currency translation adjustment

-(3)Comprehensive loss

(1,779)Non-cash stock-based compensation expense included in operating expenses:(1)  Research and development

34(2)  Sales and marketing

5436(3)  General and administrative


SOURCE Vermillion, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Vermillion Sharpens Focus and Streamlines Operations in 2012
2. Vermillion Reports Fourth Quarter and Full Year 2011 Results
3. Vermillion Reports First Quarter 2012 Results
4. Concerned Stockholders Launch Save Vermillion! Website:
5. Vermillion to Participate in Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference on February 27, 2013
6. Vermillion to Report Results for Fourth Quarter and Full Year 2012 on Wednesday, February 20, 2013
7. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
8. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
9. Interleukin Genetics Reports Third Quarter 2011 Financial Results
10. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
11. Nile Therapeutics Reports 2011 Third Quarter Financial Results
Post Your Comments:
(Date:10/8/2015)... , Oct. 8, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. ... company focused on the development of autologous cell therapies, today ... partnering meetings taking place in the month of October: ... Partnering Forum RepliCel will be presenting at the ... on the Mesa to be held October 7-9 in ...
(Date:10/8/2015)... ... October 08, 2015 , ... Talon Innovations, a provider of ... other technology-driven industries, announces that it is one of three finalists for the Minnesota ... On Thursday, September 25 Talon Innovations was recognized as a nominee for this ...
(Date:10/7/2015)... , October 8, 2015 ... Medical biotechnology accounts for largest bioinformatics ... bioinformatics in drug discovery and development process ... . --> ... On the basis of applications, the bioinformatics ...
(Date:10/7/2015)... Worth, Texas (PRWEB) , ... October 07, 2015 ... ... Cell Institute ( ) will present a public educational seminar on the ... on Saturday, October 10th from 1:00 pm – 3:00 pm at the Hilton ...
Breaking Biology Technology:
... Private Life Science Companies from ... Southern California, ... life science community, is proud to announce that its,second annual BIOCOM ... from Oct. 31-Nov. 2, 2007. Featuring almost 60 innovative public ...
... ADVENTRX Pharmaceuticals,Inc. (Amex: ANX ), ... commercializing proprietary product candidates for the treatment,of ... Evan M. Levine,ADVENTRX,s chief executive officer, is ... Annual Growth Conference on Wednesday,September 19th, 2007 ...
... Agreement, COPENHAGEN, September 13 Genmab A/S ... exchange agreement with,Medarex, Inc. Under the terms of ... which targets IL-8, and Medarex will,receive full rights ... will release to each other all previously held ...
Cached Biology Technology:
(Date:10/6/2015)... LAKE CITY , Oct. 6, 2015 ... company, announced today that it has signed a contract ... monitoring services across the full range of sentences under ... Group,s President of the Americas. "This contract with the ... region of the US and advances our position as ...
(Date:10/2/2015)... 02 2015 ... "Enforcing the Law Using Biometrics" report to ... announced the addition of the "Enforcing the ... --> Research and Markets ( ... "Enforcing the Law Using Biometrics" report to ...
(Date:9/30/2015)... Sept. 30, 2015  The U.S. Court of Appeals ... key ruling in favor of Crossmatch ™, affirming ... scanner company Suprema and its U.S. partner Mentalix violated ... trade provision that declares it unlawful to engage in ... two of Crossmatch,s patents, the 5,900,993 patent and the ...
Breaking Biology News(10 mins):
... successfully aiding in the replacement of narrowed, calcified ... open-chest surgery. According to a study reported at ... for Cardiovascular Angiography and Interventions (SCAI), May 9?2, ... with the CoreValve Revalving System (CoreValve, Irvine, CA) ...
... aimed at preventing cervical cancer is nearly 100 percent effective ... for most cases of cervical cancer. Results of a nationwide ... 9 issue of the New England Journal of Medicine. , ... deaths in women worldwide, resulting in nearly half a million ...
... at UNIVET, a spin-off of the Universitat Autònoma de ... Petcare, have developed an artificial cellular model which faithfully ... allow, therefore, the carrying out of various lines of ... need to use live animals. , The basic structure ...
Cached Biology News:
Purified anti-Fanconi anemia D2-Phosphorylated (Ser222)...
... Explorer processes up to 48 lanes, 24 ... input can be from either slab gel ... primer chemistries. The detection parameters in Explorer ... analyst consistency. We have built Explorer ...
... Quality ISO 9001:2000 Certified ... All Precedures Validated, SOP's Training ... Process for All Procedures GLP Documentation Upon ... one stop shopping point for all your ...
Biology Products: